Glaxosmithkline Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
984.49
1,045.31
850.29
959.63
833.37
Other Income Qtr Cr35.0734.5435.6429.8328.11
Operating Revenues Qtr949.421,010.77814.65929.80805.26

*All values are in Cr.

Operating Expenses Qtr
657.50
689.06
584.11
672.54
587.20
Operating Profit Qtr
291.92
321.71
230.54
257.26
218.06
EBIDT Qtr Cr
326.99
360.94
266.18
289.49
82.86
Depreciation Qtr
18.80
16.86
16.41
18.10
17.11
Net Profit Qtr
229.88
252.50
182.33
194.48
45.72
Basic EPS Qtr
13.57
14.91
10.76
11.37
9.89
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -